Viridian Therapeutics Market Cap

Viridian Therapeutics has a market cap or net worth of €2.65 billion as of January 30, 2026. Its market cap has increased by 98.01% in one year.

Market Cap

2.65B

Enterprise Value

2.42B

Revenue

60.33M

Ranking

n/a

PE Ratio

n/a

Stock Price

€27.56

Market Cap Chart

Since February 14, 2017, Viridian Therapeutics's market cap has increased from 162.74M to 2.65B, an increase of 1,528.95%. That is a compound annual growth rate of 36.52%.

Market Cap History

Date	Market Cap	% Change
Jan 30, 2026	2.65B	4.80%
Dec 31, 2025	2.53B	72.47%
Dec 31, 2024	1.47B	41.55%
Dec 29, 2023	1.04B	-5.81%
Dec 30, 2022	1.10B	191.32%
Dec 31, 2021	377.62M	618.50%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Feb 14, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lechwerke AG	2.50B
Mainova AG	2.40B
Tradegate AG Wertpapierhandelsbank	2.10B
Gelsenwasser AG	1.82B
tonies SE	1.14B
Sedlmayr Grund und Immobilien AG	939.90M
Berliner Effektengesellschaft AG	879.96M
Maschinenfabrik Berthold Hermle AG	835.00M

Market Cap Rankings